Clinical trial / 2000
Titanium dioxide conjugated with LPS stimulated interleukin-1 secretion in human intestinal organ cultures and peripheral blood mononuclear cells.
Colonic biopsy samples from 28 ulcerative colitis patients, 21 Crohn's disease patients, and 36 healthy controls, along with peripheral blood mononuclear cells, were incubated alone, with LPS, with titanium dioxide (TiO2), or with a TiO2-LPS conjugate. The TiO2-LPS conjugate stimulated peripheral blood mononuclear cells with IL-1 values 30-60-fold above controls, compared to minor stimulation with LPS or TiO2 alone. In intestinal organ cultures, TiO2 alone or LPS up to 2,000 ng/ml did not increase IL-1, but the TiO2-LPS conjugate produced a significant two-to-three-fold increase in IL-1 secretion.
- Study type
- Ex vivo controlled experiment on human tissue and cells
- Who was studied
- Colonic biopsies from 28 patients with ulcerative colitis, 21 with Crohn's disease, and 36 healthy controls, plus PBMCs
- What was measured
- Interleukin-1 (IL-1) production and secretion
THE PAPER
Immune potentiation of ultrafine dietary particles in normal subjects and patients with inflammatory bowel disease.
Powell JJ, Harvey RS, Ashwood P, Wolstencroft R, Gershwin ME, Thompson RP. J Autoimmun, 2000.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.